Genmab Ownership | Who Owns Genmab?

Genmab Ownership Summary

Genmab is owned by 16.69% institutional investors, and 83.31% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of GMAB shares. AllianceBernstein US L/C Growth Eqty MF is the top mutual fund, with 0.64% of its assets in Genmab shares.

GMAB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Genmab	16.69%	-	83.31%
Sector	Healthcare Stocks	50.50%	12.33%	37.17%
Industry	Biotech Stocks	49.09%	12.06%	38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	5.08M	7.78%	$127.67M
Paradigm biocapital advisors lp	13.13M	2.14%	$360.77M
Orbis allan gray	11.37M	1.85%	$312.28M
Alliancebernstein	8.64M	1.41%	$231.94M
Deerfield management company, l.p. (series c)	6.87M	1.12%	$188.58M
Deep track capital, lp	5.65M	0.92%	$155.21M
Arrowstreet capital, limited partnership	4.98M	0.81%	$136.67M
Blackrock funding, inc. /de	4.67M	0.76%	$128.32M
Sofinnova investments	4.05M	0.66%	$111.12M
Renaissance	3.52M	0.57%	$96.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Superstring capital management lp	430.60K	7.47%	$11.83M
Paradigm biocapital advisors lp	13.13M	6.76%	$360.77M
Sofinnova investments	4.05M	5.74%	$111.12M
Ikarian capital	175.00K	5.35%	$53.02M
Deep track capital, lp	5.65M	2.26%	$155.21M
Deerfield management company, l.p. (series c)	6.87M	1.97%	$188.58M
Aimz investment advisors	160.91K	1.22%	$4.42M
Terra nova asset management	64.24K	1.08%	$1.76M
Orbis allan gray	11.37M	1.07%	$312.28M
Harding loevner lp	3.09M	0.82%	$86.90M

Top Buyers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	13.13M	6.76%	5.17M
Deerfield management company, l.p. (series c)	6.87M	1.97%	4.40M
Sofinnova investments	4.05M	5.74%	3.29M
Citadel advisors	2.48M	0.01%	2.48M
Deep track capital, lp	5.65M	2.26%	1.99M

Top Sellers

Holder	Shares	% Assets	Change
Capital investors	-	-	-2.57M
Wellington management group llp	-	-	-2.31M
Orbis allan gray	11.37M	1.07%	-1.56M
Alliancebernstein	8.64M	0.08%	-912.27K
Renaissance	3.52M	0.13%	-896.70K

New Positions

Holder	Shares	% Assets	Change	Value
Dixon mitchell investment counsel	416.00K	0.37%	416.00K	$11.43M
Caption management	199.77K	0.03%	199.77K	$5.49M
Ikarian capital	175.00K	5.35%	175.00K	$53.02M
Sixth street partners management company	139.13K	0.00%	139.13K	$3.82M
Point72 asset management	135.65K	0.00%	135.65K	$3.73M

Sold Out

Holder	Change
Zurcher kantonalbank (zurich cantonalbank)	-1.00
Deutsche bank ag\	-4.00
Bear mountain capital	-6.00
Mendota financial group	-8.00
Baillie gifford	-12.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	303	8.60%	102,423,616	25.15%	16	9.46%	151	0.67%	101	6.32%
Mar 31, 2026	146	-50.34%	8,396,925	-88.53%	1	0.96%	74	-63.00%	48	-5.88%
Dec 31, 2025	222	-12.60%	29,400,140	-52.44%	4	4.76%	148	-10.84%	38	-37.70%
Sep 30, 2025	179	-15.96%	28,573,191	-37.70%	4	0.09%	120	5.26%	40	-44.44%
Jun 30, 2025	219	-3.52%	63,692,065	-1.88%	99	0.96%	116	-11.45%	74	12.12%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
AllianceBernstein US L/C Growth Eqty MF	3.95M	0.64%	-
iShares Biotechnology ETF	3.82M	0.61%	-16.85K
Orbis SICAV Intl Eq Inv	3.09M	0.50%	-306.17K
First Trust NYSE Arca Biotech ETF	3.14M	0.50%	-28.64K
Vanguard Health Care Inv	2.29M	0.36%	-
T. Rowe Price International Gr Eq SMA	1.90M	0.30%	1.90M
Orbis SICAV Global Bal Instl Inv	1.79M	0.29%	378.79K
AB Large Cap Growth A	1.69M	0.27%	-156.45K
Xtrackers S&P 500 Swap ETF 1C	1.02M	0.16%	1.02M
Orbis Global Equity Investor	977.99K	0.16%	-328.51K

GMAB Ownership FAQ

Who Owns Genmab?

Genmab shareholders are primarily institutional investors at 16.69%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Genmab's industry, Biotech Stocks , is 49.09%, which Genmab falls below.

Who owns the most shares of Genmab?

Genmab’s largest shareholders are Blackrock (5.08M shares, 7.78%), Paradigm biocapital advisors lp (13.13M shares, 2.14%), and Orbis allan gray (11.37M shares, 1.85%). Together, they hold 11.77% of Genmab’s total shares outstanding.

Does Blackrock own Genmab?

Yes, BlackRock owns 7.78% of Genmab, totaling 5.08M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 127.67M$. In the last quarter, BlackRock increased its holdings by 13.43K shares, a 0.27% change.

Who is Genmab’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Genmab’s biggest shareholder by percentage of total assets invested, with 7.47% of its assets in 430.6K Genmab shares, valued at 11.83M$.

Who is the top mutual fund holder of Genmab shares?

AllianceBernstein US L/C Growth Eqty MF is the top mutual fund holder of Genmab shares, with 0.64% of its total shares outstanding invested in 3.95M Genmab shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools